Clinical Trials Directory

Trials / Completed

CompletedNCT02147327

Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
Sex
All
Age
30 Minutes
Healthy volunteers
Not accepted

Summary

Cholecalciferol (vitamin D3) is a prohormone and its active form is 1,25 dihydroxycholecalciferol. This hormone has effect on both calcium, phosphorus and bone metabolism and also bone morrow, muscle, heart and immune system. For a long time, maternal low vitamin D level is a well known problem for our country and the level was reported as \<10 ng/ml for 46-80% of mothers.The most prominent risk factor was determined as low socioeconomic status. Therefore, the level of 25-hydroxy-vitamin D is supposed to be in relation with several neonatal morbidities and maternal complications of pregnancy.

Conditions

Timeline

Start date
2013-10-01
Primary completion
2014-03-01
Completion
2014-05-01
First posted
2014-05-26
Last updated
2014-05-29

Source: ClinicalTrials.gov record NCT02147327. Inclusion in this directory is not an endorsement.

Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities (NCT02147327) · Clinical Trials Directory